In a statement to CBS News about this lawsuit and others against it, Novo Nordisk said in part, "The known risks and benefits of semaglutide and liraglutide medicines are described in their FDA-approved product labeling." The company wrote that "the allegations in the lawsuits are without merit" and said it intends to "vigorously defend against these claims." Novo Nordisk also said semaglutide, the drug sold under the Ozempic and Wegovy brand names, has been extensively examined in robust clinical development programs and large real world evidence studies
Drugs like semaglutide and tirzepatide, sold as Ozempic, Wegovy, Mounjaro, and Zepbound, have been studied exhaustively for what they do to blood sugar, appetite, and weight
How to Know if Youre a Good Candidate for GLP-1 Injections Determining if GLP-1 injections are right for you starts with a consultation with a qualified provider
Through this study, we attempted to confirm that anisomycin has multiple targets and many mechanisms of action in inhibiting the activity of OCSCs
We compile medical necessity documentation, submit it to insurers, and follow up to secure approval
Dyspnea is the most common presenting symptom, often prompting initial medical consultation, while chronic dry cough and velcro-like crackles on auscultation are also characteristic clinical features [1, 2]